Skip to main content
Equibles
SYK logo

SYK · Stryker Corp · Metrics

Track SYK — free

Use SYK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SYK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$297.60 -6.80 (-2.23%) At close · Oct 21
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$116.76B
Shares
383.57M
Volume · Oct 21 2.41M Avg daily vol (3M) 2.65M

SYK metrics

118 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$297.60
Market cap
$116.76B

Price action

20 metrics
Price change (1W)
+5.7%
Price change (30D)
+8.2%
Price change (3M)
-3.8%
Price change (6M)
-9.6%
Price change (YTD)
-15.3%
Price change (1Y)
-21.6%
Trailing year
Price change (5Y)
+7.7%
52-week high
$388.35
52-week low
$269.75
Change from 52-week high
-23.4%
Change from 52-week low
+10.3%
Annualized volatility
30.3%
Annualized volatility (3M)
36.0%
Beta
0.2
RSI (14D)
58.1
Price vs SMA 50
+0.1%
Price vs SMA 200
-8.7%
Avg volume (3M)
2.65M
Relative volume
0.9
Average dollar volume
$803.05M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
383.57M

Valuation

12 metrics
P / E (TTM)
30.8
Trailing earnings · reciprocal yield 3.2%
PEG ratio
0.7
EV / revenue
5.0×
reciprocal yield 20.1%
EV / EBITDA
17.9×
reciprocal yield 5.6%
EV / EBIT
23.2×
reciprocal yield 4.3%
P / sales
4.5×
reciprocal yield 22.1%
P / book
4.9
reciprocal yield 20.5%
FCF yield
4.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
24.8
reciprocal yield 4.0%
P / operating cash flow
21.1
reciprocal yield 4.7%
Earnings yield
3.2%

Historical valuation

8 metrics
P / E historical average (3Y)
41.8×
reciprocal yield 2.4%
P / E historical average (5Y)
42.5×
reciprocal yield 2.4%
EV / revenue historical average (3Y)
6.2×
reciprocal yield 16.0%
EV / revenue historical average (5Y)
6.1×
reciprocal yield 16.3%
EV / EBIT historical average (3Y)
35.2×
reciprocal yield 2.8%
EV / EBIT historical average (5Y)
36.5×
reciprocal yield 2.7%
EV / EBITDA historical average (3Y)
25.5×
reciprocal yield 3.9%
EV / EBITDA historical average (5Y)
25.5×
reciprocal yield 3.9%

Dividends & buybacks

7 metrics
Dividend yield
1.2%
Trailing 12 months
Payout ratio
35.3%
Shareholder yield
—
Dividend / share (TTM)
$3.52
Dividend growth YoY
+4.8%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
65.0%
Operating margin
21.4%
Trailing 12 months
Net margin
14.4%
Gross profit (TTM)
$16.79B
Operating profit (TTM)
$5.53B
Net income (TTM)
$3.73B
Trailing 12 months
Diluted EPS (TTM)
$9.65
FCF margin
18.2%
Effective tax rate
27.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$66.86
Gross profit per diluted share (TTM)
$43.45
Operating profit per diluted share (TTM)
$14.32
EBITDA per diluted share (TTM)
$18.52
Net income per diluted share (TTM)
$9.65
Operating cash flow per diluted share (TTM)
$14.30
Free cash flow per diluted share (TTM)
$12.17
Capital expenditures per diluted share (TTM)
$2.13
R&D per diluted share (TTM)
$4.29
Stock compensation per diluted share (TTM)
$0.65
Book value per share
$62.54

Growth

11 metrics
Revenue growth YoY
+9.4%
Year over year
Net income growth YoY
+44.3%
Revenue (TTM)
$25.84B
Trailing 12 months
EPS growth YoY
+44.1%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.8%
Revenue CAGR (5Y)
+11.8%
EPS CAGR (3Y)
+10.8%
EPS CAGR (5Y)
+14.9%
FCF CAGR (3Y)
+28.1%
FCF CAGR (5Y)
+9.0%

Quality

14 metrics
Return on equity
15.5%
Return on assets
7.8%
Debt / equity
0.6
Current ratio
2.2
EBITDA (TTM)
$7.16B
Free cash flow (TTM)
$4.70B
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
1.6
Return on invested capital
11.3%
Trailing 12 months
Net cash
−$11.55B
Latest balance sheet
Cash & equivalents
$3.39B
Total assets
$47.93B
Total debt
$14.94B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.53B
Capital expenditures (TTM)
$823.00M
R&D (TTM)
$1.66B
SG&A (TTM)
$8.78B
Stock compensation (TTM)
$251.00M
R&D / revenue
6.4%
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
2,278
13F filer change QoQ
-41
Institutional ownership
81.0%
Conviction holders (share of 13F filers)
2.0%
Crowding (high-turnover and private-fund holders)
12.3%
Private-fund adviser ownership
12.0%
Active holders' share change QoQ
+1.8%
Holder tenure
19.5
Price vs estimated holder cost
-4.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.3%

Short interest

3 metrics
Short interest
1.5%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$118.20M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 310764 CUSIP 863667101 13F (30d) 496 filings 468 filers Visit website Investor relations